HOME › Research Insight › New Product Launches is the Key Growth Strategy Adopted by Players Operating in the Single-use Bioreactors Market
New Product Launches is the Key Growth Strategy Adopted by Players Operating in the Single-use Bioreactors Market
Sartorius Stedim Biotech SA (France) and Merck Millipore (Germany) are the leading players in the global single-use bioreactors market. The strong position of these companies in the market can primarily be attributed to their global presence and broad product portfolio. Other major players in the market include GE Healthcare (U.S.), Danaher Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
In 2016, Sartorius Stedim Biotech SA (France) held the largest market share of ~34%. Over the past three years, the company adopted the strategies of new product launches and strategic acquisitions to maintain its position in the global single-use bioreactors market. In June 2016, Sartorius Stedim Biotech launched ambr 250, a benchtop mini bioreactor system for parallel fermentation or cell culture. This product offers access to advanced benchtop bioreactor technology for process development with the combination of a single-use bioreactor vessel and expandable system design.
Thermo Fisher, another major player operating in this market, offers single-use mixers, single-use bioreactors, single-use fermenters, and single-use bioreactor controllers. In order to maintain its dominance in the single-use bioreactors market, the company primarily adopted the strategy of new product launches. In March 2014, Thermo Fisher Scientific unveiled a single-use bioreactor controller platform in collaboration with Applikon Biotechnology (Netherlands). The product delivers exceptional versatility, high performance, simple operation, and reduced setup and installation time. Thermo Fisher Scientific owns the marketing rights of the product and through this collaboration, the company has strengthened its relationship with Applikon for assuring better services to its customers.
The single-use bioreactors market is in different phases of growth in different regions. In North America and Europe, the market is in a mature phase with several key players opting to reduce the cost of research and manufacturing and eliminating the risk of cross-contamination.
Companies in the single-use bioreactors market are majorly focusing on new product launches for strengthening their market share; this strategy accounted for ~53% of the total number of strategic developments undertaken by key players in this market.
Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India